Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome

Background: Treatment for critical care conditions, such as acute respiratory distress syndrome (ARDS), requires ready-to-administer injectable mesenchymal stromal cells (MSCs). A validated cryopreserved therapy based on MSCs derived from menstrual blood (MenSCs) is an attractive option that offers...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcayaga-Miranda, Francisca, Dutra Silva, Johnatas, Parada, Nicol, Andrade da Silva, Luisa Helena, Ferreira Cruz, Fernanda, Utreras, Yildy, Hidalgo, Yessia, Cádiz, María Ignacia, Tapia Limonchi, Rafael, Espinoza, Francisco, Bruhn, Alejandro, Khoury, Maroun, R. M. Rocco, Patricia, Cuenca, Jimena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923023/
https://www.ncbi.nlm.nih.gov/pubmed/36793446
http://dx.doi.org/10.3389/fcell.2023.1031331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923023/
https://www.ncbi.nlm.nih.gov/pubmed/36793446
http://dx.doi.org/10.3389/fcell.2023.1031331

Ejemplares similares